SCHEMBL24517309

SCHEMBL24517309

CS(C)(C)C#Cc1c(-c2ccc(F)cc2)nc2ccccn12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.53
▸ KDM4E B2RXH2 6/20 0.51
▸ HPGD P15428 2/20 0.51
▸ NPC1 O15118 7/20 0.44
▸ RAB9A P51151 7/20 0.44
▸ MAPT P10636 3/20 0.44
▸ FLT3 P36888 1/20 0.43
▸ MAPK13 O15264 1/20 0.40
▸ MAPK12 P53778 1/20 0.40
▸ MAPK11 Q15759 1/20 0.40
▸ MAPK14 Q16539 1/20 0.40
▸ GAA P10253 2/20 0.40
▸ HTR6 P50406 1/20 0.40
▸ PKM P14618 1/20 0.40
▸ PKLR P30613 1/20 0.40
▸ ADRA1B P35368 1/20 0.39
▸ BACE1 P56817 1/20 0.39
▸ BACE2 Q9Y5Z0 1/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ POLB P06746 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24517687 0.88 NPC1 (0.54) ALDH1A1KDM4EHPGDNPC1RAB9A
SCHEMBL24517305 0.87 KDM4E (0.53) ALDH1A1KDM4ENPC1RAB9AMAPT
SCHEMBL24517691 0.86 NTRK1 (0.46) ALDH1A1KDM4EHPGDNPC1RAB9A
SCHEMBL24517390 0.85 RAD51 (0.43) ALDH1A1KDM4EHPGDNPC1RAB9A
SCHEMBL24517330 0.85 PLAU (0.46) ALDH1A1KDM4EHPGDNPC1RAB9A
SCHEMBL24517108 0.85 KDM4E (0.44) ALDH1A1KDM4ENPC1RAB9AMAPT
SCHEMBL24517111 0.85 NPC1 (0.61) ALDH1A1KDM4EHPGDNPC1RAB9A
SCHEMBL22614960 0.83 ALDH1A1 (0.54) ALDH1A1KDM4EHPGDNPC1RAB9A
SCHEMBL24516940 0.83 ADORA1 (0.43) ALDH1A1KDM4EHPGDNPC1RAB9A
SCHEMBL24517326 0.82 RAB9A (0.46) ALDH1A1KDM4ENPC1RAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220185822-A1 SELECTIVE LIGANDS OF HUMAN CONSTITUTIVE ANDROSTANE RECEPTOR USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR, V.V.I. (CZ) 2022-06-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220185822-A1 SELECTIVE LIGANDS OF HUMAN CONSTITUTIVE ANDROSTANE RECEPTOR NR1I2, NR1H2, NR1H4 ALDH1A1 435/4885KDM4E 4721/4885HPGD 718/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback